Quality-adjusted life years for digital cognitive behavioural therapy for insomnia (Sleepio): a secondary analysis by Stokes, EA, Stott, R, Henry, AL, Espie, CA, Miller, CB

The clinical effects of sleep restriction therapy for insomnia: a meta-analysis of randomised controlled trials by Maurer, LF, Schneider, J, Miller, CB, Espie, CA, Kyle, SD

Sham sleep feedback delivered via actigraphy biases daytime symptom reports in people with insomnia: Implications for insomnia disorder and wearable devices by Gavriloff, D, Sheaves, B, Juss, A, Espie, CA, Miller, CB, Kyle, SD

Does treating insomnia with digital cognitive behavioural therapy (Sleepio) mediate improvements in anxiety for those with insomnia and comorbid anxiety? An analysis using individu... by Henry, AL, Miller, CB, Emsley, R, Sheaves, B, Freeman, D, Luik, AI, Espie, CA

Validity and Reliability of the Turkish Version of the Sleep Condition Indicator: A Clinical Screening Instrument Based on the DSM-5 Criteria for Insomnia by Uygur H, Ahmed O, Uygur OF, Miller CB, Hursitoglu O, Bahar A, Demiroz D, Drake CL

Get full text

Insomnia as a mediating therapeutic target for depressive symptoms: a sub‐analysis of participant data from two large randomized controlled trials of a digital sleep intervention by Henry, AL, Miller, CB, Emsley, R, Sheaves, B, Freeman, D, Luik, AI, Littlewood, DL, Saunders, KEA, Kanady, JC, Carl, JR, Davis, ML, Kyle, SD, Espie, CA

Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis by Gerds, AT, Savona, MR, Scott, BL, Talpaz, M, Egyed, M, Harrison, CN, Yacoub, A, Vannucchi, A, Mead, AJ, Kiladjian, J-J, O'Sullivan, J, García-Gutiérrez, V, Bose, P, Rampal, RK, Miller, CB, Palmer, J, Oh, ST, Buckley, SA, Mould, DR, Ito, K, Tyavanagimatt, S, Smith, JA, Roman-Torres, K, Devineni, S, Craig, AR, Mascarenhas, JO